Q. The i.v. bolus dosage is 500mg and the plasma drug concentration is 0.8 mg/ml. What should be the volume of distribution?

View solution

Q. To have a plasma distribution value of 900 ml and plasma drug concentration to be 1.2 mg/ml what should be the amount of drug that should be given to the patient?

View solution

Q. What is the equation to find out hepatic clearance?

View solution

Q. Which organs comprise the central compartment in a two compartment model?

View solution

Q. Which organ comprises the peripheral compartment in a two compartment model?

View solution

Q. Which of the following is not a category of 2 compartment model?

View solution

Q. Any changes in fraction bioavailable, elimination half-life indicates nonlinearity of that particular drug.

View solution

Q. Which of the following creates nonlinearity in drug distribution and not in drug absorption?

View solution

Q. Which one of these are correct Michaelis-Menten equation?

View solution

Q. What is bioavailability?

View solution

Q. What is the equation of bioavailable fraction?

View solution

Q. Which of the following is not an objective of bioavailability studies?

View solution

Q. Single-dose bioavailability studies are simple and common.

View solution

Q. Multiple dose study is better since we can understand the peak, valley, drug blood levels, etc.

View solution

Q. Which of the following is the pharmacodynamics method of studying bioavailability?

View solution

Q. Which of the following is not an important parameter of plasma level time studies?

View solution

Q. What is the equation for bioavailability?

View solution

Q. The urinary excretion of the unchanged drug is directly proportional to the plasma concentration of a drug.

View solution

Q. Which of the following will not be a parameter that should be examined for urinary excretion data?

View solution

Q. Which of the following is not measured in acute pharmacological response study?

View solution